feed,title,long_url,short_url
Benzinga,GeneTx and Ultragenyx Announce Presentation of Phase 1/2 Data on Investigational GTX-102 in Patients with Angelman Syndrome,https://www.benzinga.com/pressreleases/20/12/g18663455/genetx-and-ultragenyx-announce-presentation-of-phase-12-data-on-investigational-gtx-102-in-patient,https://j.mp/37Bco2g
